Seven independent research programs are interacting in a concerted effort to identify inhibitors of polyamine biosynthesis and/or function as potential antic-cancer agents with the ultimate coal of utilizing those agents to improve the treatment and curability of human cancer. The impetus for this study derives, in part, from the dependence of neoplastic cell growth on sustained polyamine biosynthesis and the increased rate of this activity in neoplastic cells relative to their normal counterparts. Agents being synthesized by three chemistry programs include: polyamine analogs and conjugates (Dr. R. Bergeron, U. of Florida, Gainesville), inhibitors of spermidine and spermine synthases and the processing of S-adenosylmethionine (AdoMet metabolism (Dr. J. Sufrin, Roswell Park Memorial Institute, Buffalo, NY). These and compounds derived from outside sources are being tested for biochemical effects on polyamine biosynthesis and molecular biology (Dr. A. Pegg, Penn. State University, Hershey, PA), for cellular effects and antiproliferative activity in the in vitro and in vivo (Dr. C. Porter, P.I.), for drug interaction studies with DNA and DNA-reactive antineoplastics (Drs. L. Marton and D. Deen, U. California, San Francisco), and for drug effects on human lung carcinoma growth in vitro and in vivo (Drs. R. Casero and S. Baylin, Johns Hopkins, Baltimore, MD). Compounds currently being studied within the various programs include: AdoDATO and AdoDATAD, inhibitors, respectively, of spermidine and spermine synthase; AdoMet analog inhibitors of AdoMet decarboxylase; DFMO and related inhibitors of ornithine decarboxylase; bisalkyl analogs of spermidine and spermine; analogs of 5'-deoxy-5-methylthioadenosine and others. Data generated by the various biological evaluation programs provides continual feedback information for the design and synthesis of additional compounds. While it is the primary goal of this group effort to identify new and practical anticancer treatments, information relevant to the role and function that poyamines fulfill in cell proliferation will also be sought, thus enhancing our understanding of the neoplastic process in general.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA037606-07
Application #
3548437
Study Section
Special Emphasis Panel (SRC (M2))
Project Start
1984-09-01
Project End
1992-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Mi, Z; Kramer, D L; Miller, J T et al. (1998) Human prostatic carcinoma cell lines display altered regulation of polyamine transport in response to polyamine analogs and inhibitors. Prostate 34:51-60
Kramer, D L; Fogel-Petrovic, M; Diegelman, P et al. (1997) Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Res 57:5521-7
Bergeron, R J; Yao, G W; Yao, H et al. (1996) Metabolically programmed polyamine analogue antidiarrheals. J Med Chem 39:2461-71
Bergeron, R J; Weimar, W R; Wu, Q et al. (1996) Polyamine analogue regulation of NMDA MK-801 binding: a structure-activity study. J Med Chem 39:5257-66
Fogel-Petrovic, M; Vujcic, S; Brown, P J et al. (1996) Effects of polyamines, polyamine analogs, and inhibitors of protein synthesis on spermidine-spermine N1-acetyltransferase gene expression. Biochemistry 35:14436-44
Lakanen, J R; Pegg, A E; Coward, J K (1995) Synthesis and biochemical evaluation of adenosylspermidine, a nucleoside-polyamine adduct inhibitor of spermidine synthase. J Med Chem 38:2714-27
Bergeron, R J; McManis, J S; Weimar, W R et al. (1995) The role of charge in polyamine analogue recognition. J Med Chem 38:2278-85
Bernacki, R J; Oberman, E J; Seweryniak, K E et al. (1995) Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Clin Cancer Res 1:847-57
Sufrin, J R; Meshnick, S R; Spiess, A J et al. (1995) Methionine recycling pathways and antimalarial drug design. Antimicrob Agents Chemother 39:2511-5
Bergeron, R J; McManis, J S; Liu, C Z et al. (1994) Antiproliferative properties of polyamine analogues: a structure-activity study. J Med Chem 37:3464-76

Showing the most recent 10 out of 121 publications